Prashanth Kandaswamy

Prashanth Kandaswamy is a seasoned professional in market access and health economics, currently serving as the Head of Market Access for the UK, Ireland, and Nordics at Grünenthal Group since April 2017. In this role, Prashanth leads global market access strategies for a new treatment for pain associated with knee osteoarthritis, ensuring access needs are integrated into R&D and preparing comprehensive value dossiers. Previous experience includes significant roles at Boehringer Ingelheim, where responsibilities encompassed market access strategy for diabetes products, and at the National Institute for Health and Clinical Excellence, providing strategic oversight on health economic issues. Prashanth holds an MSc in Health Economics and Health Policy from the University of Birmingham and a BA in Economics and Mathematics from Lancaster University.